Epidemiology, definition and treatment of complicated urinary tract infections

FME Wagenlehner, TE Bjerklund Johansen… - Nature Reviews …, 2020 - nature.com
UTIs are amongst the most frequent bacterial infections. However, the clinical phenotypes of
UTI are heterogeneous and range from rather benign, uncomplicated infections to …

Metallo-β-lactamases: structure, function, epidemiology, treatment options, and the development pipeline

SE Boyd, DM Livermore, DC Hooper… - Antimicrobial agents …, 2020 - Am Soc Microbiol
Modern medicine is threatened by the global rise of antibiotic resistance, especially among
Gram-negative bacteria. Metallo-β-lactamase (MBL) enzymes are a particular concern and …

[HTML][HTML] European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram …

M Paul, E Carrara, P Retamar, T Tängdén… - Clinical Microbiology …, 2022 - Elsevier
Scope These ESCMID guidelines address the targeted antibiotic treatment of third-
generation cephalosporin-resistant Enterobacterales (3GCephRE) and carbapenem …

Oral tebipenem pivoxil hydrobromide in complicated urinary tract infection

PB Eckburg, L Muir, IA Critchley… - … England Journal of …, 2022 - Mass Medical Soc
Background There is a need for oral antibiotic agents that are effective against multidrug-
resistant gram-negative uropathogens. Tebipenem pivoxil hydrobromide is an orally …

Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents

MS Bader, M Loeb, D Leto, AA Brooks - Postgraduate medicine, 2020 - Taylor & Francis
Urinary tract infections (UTIs) caused by antibiotic-resistant Gram-negative bacteria are a
growing concern due to limited treatment options. Knowledge of the common uropathogens …

Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology, prognosis and treatment options

S Karakonstantis, EI Kritsotakis… - Journal of Antimicrobial …, 2020 - academic.oup.com
Background The literature on the epidemiology, mortality and treatment of pandrug-resistant
(PDR) Gram-negative bacteria (GNB) is scarce, scattered and controversial. Objectives To …

[HTML][HTML] Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an …

S Karakonstantis, EI Kritsotakis, A Gikas - Infection, 2020 - Springer
The management of carbapenem-resistant infections is often based on polymyxins,
tigecycline, aminoglycosides and their combinations. However, in a recent systematic …

Effect of cefepime/enmetazobactam vs piperacillin/tazobactam on clinical cure and microbiological eradication in patients with complicated urinary tract infection or …

KS Kaye, A Belley, P Barth, O Lahlou, P Knechtle… - Jama, 2022 - jamanetwork.com
Importance Cefepime/enmetazobactam is a novel β-lactam/β-lactamase inhibitor
combination and a potential empirical therapy for resistant gram-negative infections …

Current and future perspectives in the treatment of multidrug-resistant Gram-negative infections

M Bassetti, J Garau - Journal of Antimicrobial Chemotherapy, 2021 - academic.oup.com
Microbial resistance is a serious threat to human health worldwide. Among the World Health
Organisation's list of priority resistant bacteria, three are listed as critical—the highest level of …

[图书][B] The WHO AWaRe (access, watch, reserve) antibiotic book

World Health Organization - 2022 - books.google.com
There is a clear need for simple resources to improve the quality of antibiotic prescribing
globally. The AWaRe book was designed as a tool to make the antibiotics section of the …